House lawmaker brings FDA into biosecurity crackdown on China

Amid a U.S. biosecurity crackdown on certain Chinese life sciences service providers, the House Committee on Oversight and Accountability is dialing up the pressure by unleashing a salvo of letters to different government agencies—including the U.S. Food and Drug Administration.